Conclusions: We conclude that OA is an effective treatment in some patients with mild-moderate OSA and is associated with fewer side effects and greater patient satisfaction than N-CPAP. (CHEST 1996; 109:1269-75) 
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shown that average usage is less than 50% The questionnaire symptom data were grouped into three pos¬ sible responses.improved, unchanged, or worse. The data were then compared in the same manner as described above before ( Fig 3) . AHI was lower with N-CPAP than OA (p<0.05). There was also These studies should include objective assessment of daytime performance, covert compliance monitoring, and long-term follow-up.
